{"pub": "yahoo", "url": "https://finance.yahoo.com/m/b9568563-6b68-33c6-bc75-f5752f046585/the-long-decline-in-abbvie-is.html", "downloaded_at": "2019-10-18 01:16:28.800427+00:00", "title": "The Long Decline in AbbVie Is Over", "language": "en", "text": "The Long Decline in AbbVie Is Over More\n\nIn his \"No-Huddle Offense\" segment of Mad Money Wednesday night, Jim Cramer said that as the market is slaughtering the high-growth stocks, those with dividends are coming back into fashion. Cramer said Wall Street is only now waking up to just how transformative Allergan will be to AbbVie, and now's the time to take advantage as the combined company will have both growth and an excellent dividend yield. In this daily bar chart of ABBV, below, we can see that prices have declined the past 12 months but now ABBV is testing the declining 200-day moving average line and the slope of the 50-day moving average line is positive.", "description": "In his \"No-Huddle Offense\" segment of Mad Money Wednesday night, Jim Cramer said that as the market is slaughtering the high-growth stocks, those with dividends are coming back into fashion.  Cramer said Wall Street is only now waking up to just how transformative Allergan will be to AbbVie, and now's the time to take advantage as the combined company will have both growth and an excellent dividend yield.  In this daily bar chart of ABBV, below, we can see that prices have declined the past 12 months but now ABBV is testing the declining 200-day moving average line and the slope of the 50-day moving average line is positive.", "authors": [], "top_image": "https://s.yimg.com/uu/api/res/1.2/br.wM1Tq2E4fhR.v2TtuHw--~B/aD04MjA7dz03MjA7c209MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/thestreet.com/2f18b2a1ee4cff5544d1103c91e7dc0f", "published_at": "2019-10-17"}